864082-33-7 Usage
Uses
Used in Pharmaceutical Applications:
2-Methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxylic acid is used as a potential pharmaceutical candidate due to its unique structure, which suggests it could possess biological activity. This makes it a promising compound for the development of new drugs.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-Methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxylic acid is used as a building block for the creation of more complex molecules. Its versatile structure allows for various chemical reactions, facilitating the synthesis of new compounds.
Used in Agrochemical Development:
2-Methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxylic acid is used in the development of agrochemicals, where its properties may contribute to the creation of effective pesticides or other agricultural products.
Used in Materials Science Applications:
In materials science, 2-Methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxylic acid is used for its potential to contribute to the development of new materials with unique properties, such as improved stability or reactivity.
2-Methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxylic acid is of interest to researchers and professionals in the fields of chemistry, pharmacology, and material sciences due to its complex and specialized nature.
Check Digit Verification of cas no
The CAS Registry Mumber 864082-33-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,0,8 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 864082-33:
(8*8)+(7*6)+(6*4)+(5*0)+(4*8)+(3*2)+(2*3)+(1*3)=177
177 % 10 = 7
So 864082-33-7 is a valid CAS Registry Number.
864082-33-7Relevant articles and documents
Development of dihydropyridone indazole amides as selective rho-kinase inhibitors
Goodman, Krista B.,Cui, Haifeng,Dowdell, Sarah E.,Gaitanopoulos, Dimitri E.,Ivy, Robert L.,Sehon, Clark A.,Stavenger, Robert A.,Wang, Gren Z.,Viet, Andrew Q.,Xu, Weiwei,Ye, Guosen,Semus, Simon F.,Evans, Christopher,Fries, Harvey E.,Jolivette, Larry J.,Kirkpatrick, Robert B.,Dul, Edward,Khandekar, Sanjay S.,Yi, Tracey,Jung, David K.,Wright, Lois L.,Smith, Gary K.,Behm, David J.,Bentley, Ross,Doe, Christopher P.,Hu, Erding,Lee, Dennis
, p. 6 - 9 (2007/10/03)
Rho kinase (ROCK1) mediates vascular smooth muscle contraction and is a potential target for the treatment of hypertension and related disorders. Indazole amide 3 was identified as a potent and selective ROCK1 inhibitor but possessed poor oral bioavailabi
NOVEL COMPOUNDS
-
Page/Page column 30, (2008/06/13)
Novel inhibitors of Rho-kinases are disclosed.